Paper Details

  1. Home
  2. Paper Details

An ezetimibe-policosanol combination has the potential to be an OTC agent that could dramatically lower LDL cholesterol without side effects.

Author: McCartyMark F

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

LDL cholesterol is a major risk factor for heart disease. Dietary changes have a limited impact on LDL cholesterol, and most cholesterol-lowering drugs have side effects. Policosanol and ezetimibe are two drugs with promising effects on lowering LDL cholesterol without side effects.
Paper Details　
Original Abstract of the Article :
Although many risk factors influence atherogenesis, LDL appears to play a primary role in this process. In prospective epidemiology, coronary risk increases as LDL cholesterol increases, throughout the entire range of concentrations encountered in healthy humans. Coronary risk is minimal in individu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.mehy.2003.12.051

データ提供：米国国立医学図書館（NLM）

Ezetimibe-Policosanol Combination: A Potential OTC Agent for Lowering LDL Cholesterol

High LDL cholesterol is a major risk factor for heart disease. This research explores the potential of combining ezetimibe and policosanol, two cholesterol-lowering agents, to create an over-the-counter (OTC) medication for reducing LDL cholesterol. The authors, like resourceful inventors seeking to improve health outcomes, investigate the potential of this synergistic combination for widespread application.

Ezetimibe-Policosanol: A Promising Combination for Lowering LDL Cholesterol

The study suggests that combining ezetimibe and policosanol may offer a safe and effective OTC option for lowering LDL cholesterol, potentially reducing the risk of heart disease. This research, like a well-constructed bridge connecting health and well-being, offers hope for individuals seeking to manage their cholesterol levels and improve their cardiovascular health.

Exploring New Avenues for Cholesterol Management

This research, like a desert explorer uncovering hidden springs, highlights the importance of exploring new avenues for managing cholesterol levels and promoting cardiovascular health. The authors' findings encourage continued research into the potential of this combination for improving patient outcomes and preventing heart disease.

Dr.Camel's Conclusion

This research, like a caravan carrying vital supplies across a vast and unforgiving desert, offers a promising new approach for managing cholesterol levels and reducing the risk of heart disease. The authors' findings highlight the potential of ezetimibe-policosanol combination as a safe and effective OTC option, paving the way for improved cardiovascular health and a brighter future for individuals seeking to manage their cholesterol levels.

Date :
  1. Date Completed 2005-06-23
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

15617880

DOI: Digital Object Identifier

10.1016/j.mehy.2003.12.051

Related Literature

Article Analysis
・Side Effects of ezetimibe
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.